PTHS
Pelthos Therapeutics Inc. · Healthcare · Market cap $93.2M
Insiders bought $896K net in the last 90 days ·4 sellers, 1 buyer· 4 of 5 sales under Rule 10b5-1 plans· latest Form 4 filed Jul 7, 2026
Insider Buying
$1000K
reported purchases (SEC code P)
Insider Selling
$441K
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Latest filing
Jul 7, 2026
Greenleaf Peter
Pelthos Therapeutics Inc. (PTHS) has 23 SEC Form 4 filings (44 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Jul 7, 2026.
Inside the rolling window, 6 insiders at Pelthos Therapeutics Inc. reported 1 open-market purchase totaling $1000K and 10 open-market sales totaling $441K. The most active filer is Director Friedberg Ezra M with 4 filings. Insiders have net bought $839K over the trailing 6 months. The most recent open-market filing is a sale of 797 shares by Director Greenleaf Peter, dated Jul 2, 2026, worth $21K.
- Industry:Biotechnology
- CEO:Scott Plesha
- Employees:92
- HQ:Durham, NC, US
- IPO:2024-02-16
| Source | |||||||
|---|---|---|---|---|---|---|---|
Greenleaf PeterFirst in 3 months | Director | Sale | 797 | $21K | Jul 7 | -1.0% | SEC ↗ |
Pauls MatthewFirst in 3 months | Director | Sale | 786 | $21K | Jul 7 | -1.0% | SEC ↗ |
| Director | Sale | 558 | $15K | Jul 7 | -1.0% | SEC ↗ | |
| Director | Sale | 283 | $8K | Jun 17 | -9.8% | SEC ↗ | |
Davis Todd CFirst filing | Director | Purchase | 35,948 | $1000K | Jun 15 | -8.1% | SEC ↗ |
Francis Knuettel IIFirst filing | CFO, Treas & Secty | Sale | 1,500 | $40K | May 26 | — | SEC ↗ |
Greenleaf PeterFirst filing | Director | Sale | 797 | $17K | Apr 6 | — | SEC ↗ |
Pauls MatthewFirst filing | Director | Sale | 786 | $16K | Apr 6 | — | SEC ↗ |
Malamut RichardFirst filing | Director | Sale | 590 | $12K | Apr 6 | — | SEC ↗ |
Friedberg Ezra MFirst in 4 months | Director | Sale | 558 | $12K | Apr 6 | — | SEC ↗ |
Friedberg Ezra MFirst filing | Director | Sale | 10,000 | $280K | Nov 26 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does PTHS have?
Pelthos Therapeutics Inc. (PTHS) has 23 SEC Form 4 filings (44 transaction rows) in the rolling 365-day window, disclosed by 6 distinct insiders. Most recent filing: Jul 7, 2026.
When was the most recent SEC Form 4 filing for PTHS?
The most recent Form 4 filing for PTHS on Tracefour is dated Jul 7, 2026.
Who is the most active insider at PTHS?
The most active SEC Form 4 filer at PTHS in the rolling window is Director Friedberg Ezra M, with 4 filings.
What is the net insider flow at PTHS over the last 6 months?
Over the trailing 180 days, insiders at PTHS have net bought $839K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at PTHS in the current window?
Inside the rolling window, insiders at PTHS bought $1000K and sold $441K based on SEC Form 4 filings.
Can I get alerts for PTHS insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Pelthos Therapeutics Inc. (PTHS). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Pelthos Therapeutics Inc. is in the Healthcare sector.